Cell Death and Disease (Nov 2022)

ALKBH5-mediated m6A modification of lincRNA LINC02551 enhances the stability of DDX24 to promote hepatocellular carcinoma growth and metastasis

  • Hongwei Zhang,
  • Yachong Liu,
  • Wei Wang,
  • Furong Liu,
  • Weijian Wang,
  • Chen Su,
  • He Zhu,
  • Zhibin Liao,
  • Bixiang Zhang,
  • Xiaoping Chen

DOI
https://doi.org/10.1038/s41419-022-05386-4
Journal volume & issue
Vol. 13, no. 11
pp. 1 – 12

Abstract

Read online

Abstract As the most important RNA epigenetic regulation in eukaryotic cells, N6-metheyladenosine (m6A) modification has been demonstrated to play significant roles in cancer progression. However, this modification in long intergenic non-coding RNAs (lincRNAs) and the corresponding functions remain elusive. Here, we showed a lincRNA LINC02551 was downregulated by AlkB Homolog 5 (ALKBH5) overexpression in a m6A-dependent manner in hepatocellular carcinoma (HCC). Functionally, LINC02551 was required for the growth and metastasis of HCC. Mechanistically, LINC02551, a bona fide m6A target of ALKBH5, acted as a molecular adaptor that blocked the combination between DDX24 and a E3 ligase TRIM27 to decrease the ubiquitination and subsequent degradation of DDX24, ultimately facilitating HCC growth and metastasis. Thus, ALKBH5-mediated LINC02551 m6A methylation was required for HCC growth and metastasis.